UNSPSC 51182072: Testosterone heptanoate

This classification denotes an androgen with the molecular formula C26H40O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7Z6522T8N9, chemically known as androst-4-en-3-one, 17-(1-oxoheptyl)oxy-, (17.beta.)-, but more generally known as testosterone heptanoate, which bears US NIH Compound Identifier 9416. European Medicines Agency schedules testosterone heptanoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10937MIG.

Most nations, for tariff purposes, schedule testosterone heptanoate under HS 29372900. SMILES: CCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.

UNSPSC 51182072 Testosterone heptanoate is a Commodity code covering a synthetic androgenic steroid pharmaceutical product. The source provided contains no recent state and local contract opportunities soliciting this substance. Without evidence of current procurement activity, state and local governments do not appear to be actively buying testosterone heptanoate through posted solicitations.

The absence of recent opportunities under this code suggests that if state and local procurement does occur in this pharmaceutical category, it is either minimal, handled through standing agreements or cooperative purchasing vehicles not reflected in posted notices, or classified under broader pharmaceutical supply codes rather than this narrow commodity specification.